An FDA panel heard from physicians, public health experts, company representatives, and numerous women who said Essure had harmed them.
A new drug promising to help women restore lost libido has been approved by the FDA. But is it just a bill of goods? And does the marketing of this actually hurt the cause of women’s sexual freedom?
The Centers for Disease Control and Prevention released new data Wednesday that shows fewer teens, especially younger teens, are having sex, and the majority of those who become sexually active use contraception the first time they have sex.
Hobby Lobby supporters claim that they aren’t out to take away contraception, just to keep religious employers from paying for it. Now that the Obama administration has made that possible, however, they are still throwing fits.
For years, medication abortion ranked far behind surgical abortion in popularity. But now that may be changing, as women increasingly see the pill—legal or not—as a way to get around draconian abortion restrictions.
A number of Republicans claimed to support over-the-counter birth control pills to counter claims of being anti-contraception in 2014. Now they may have accidentally increased liberal interest in the issue, which could lead to it becoming a reality.
Efforts to promote breastfeeding as the best option for infants may have led some parents to believe formula is not a good option and to turn to the Internet to find someone else’s milk, a practice the FDA says is unsafe.
Almost no independent research has investigated the potential health impacts of long-term feminine hygiene product use. Studies have generally taken place through product manufacturers—who aren’t required to release the results in full to the public.
It’s been two years since the FDA made certain types of emergency contraception available without a prescription to women of all ages, but Indian Health Service has yet to update its policy.
Liletta, an IUD just approved by the FDA, is being marketed in the United States through a unique partnership between manufacturers who hope to bring the device to more people at a lower cost. However, it is still unclear whether those savings will be felt by all women.